Unique ID issued by UMIN | UMIN000054993 |
---|---|
Receipt number | R000061640 |
Scientific Title | A retrospective observational study of rasagiline combination therapy in early-stage Parkinson's disease patients treated with levodopa |
Date of disclosure of the study information | 2024/07/18 |
Last modified on | 2024/08/27 09:32:59 |
A retrospective observational study of rasagiline combination therapy in early-stage Parkinson's disease patients treated with levodopa
A retrospective observational study of rasagiline combination therapy in early-stage Parkinson's disease patients treated with levodopa
A retrospective observational study of rasagiline combination therapy in early-stage Parkinson's disease patients treated with levodopa
A retrospective observational study of rasagiline combination therapy in early-stage Parkinson's disease patients treated with levodopa
Japan |
Parkinson's disease
Psychiatry |
Others
NO
Using a Patient Registry for Backward-Looking Observations in Patients with Early Parkinson's Disease
Others
A backward-looking observational study
Amount of change in MDS-UPDRS PART3 score between baseline and follow-up periods
Observational
30 | years-old | <= |
Not applicable |
Male and Female
Patients who fall into any of the following categories shall be included.
(1) Patients who received * less than or equal to 300 mg/day of levodopa for more than a certain period of time during the follow-up period and subsequently received additional rasagiline.
(2) Patients who received * less than or equal to 300 mg/day of levodopa for more than a certain period of time during the follow-up period and subsequently received an increase in the dose of levodopa.
*The number of days to ensure the necessary number of patients should be considered after conducting a feasibility study.
The index date will be the date of the first dose of lasagiline in (1) and the date of dose escalation from the maximum dose of levodopa of 300 mg/day or less in (2).
The patients in (1) will be designated as subgroup 1, and those in (2) as subgroup 2.
Exclude patients who meet the following criteria
Patients with a history of DBS prior to the Index date
80
1st name | Miwa |
Middle name | |
Last name | Izutsu |
Takeda Pharmaceutical Company Limited.
Japan Medical Office
103-8668
1-1, Nihonbashi-Honcho 2-Chome, Chuo-ku, Tokyo, 103-8668, Japan
03-3278-2111
miwa.izutsu@takeda.com
1st name | Yukiko |
Middle name | |
Last name | Kobayashi |
Takeda Pharmaceutical Company Limited.
Japan Medical Office
103-8668
1-1, Nihonbashi-Honcho 2-Chome, Chuo-ku, Tokyo, 103-8668, Japan
03-3278-2111
yukiko.kobayashi@takeda.com
Takeda Pharmaceutical Company Limited.
Takeda Pharmaceutical Company Limited.
Profit organization
University of Tsukuba Hospital Clinical Research Ethics Review Committee
2-1-1 Amakubo, Tsukuba, Ibaraki 305-8576 Japan
029-853-3914
t-credo.adm@un.tsukuba.ac.jp
NO
2024 | Year | 07 | Month | 18 | Day |
Unpublished
No longer recruiting
2024 | Year | 02 | Month | 14 | Day |
2024 | Year | 07 | Month | 08 | Day |
2024 | Year | 05 | Month | 31 | Day |
2024 | Year | 05 | Month | 31 | Day |
Retrospective observational study in Parkinson's disease patients using a patient registry
2024 | Year | 07 | Month | 17 | Day |
2024 | Year | 08 | Month | 27 | Day |
Value
https://center6.umin.ac.jp/cgi-open-bin/icdr_e/ctr_view.cgi?recptno=R000061640
Research Plan | |
---|---|
Registered date | File name |
Research case data specifications | |
---|---|
Registered date | File name |
Research case data | |
---|---|
Registered date | File name |